Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Listen To Our Podcast Interview With AdvaMed’s Scott Whitaker

Executive Summary

The head of the industry advocacy group talked about new priorities for the industry in light of the COVID-19 crisis, his thoughts on how the government and industry have responded, and what his group is doing to help companies cope with the financial burdens they may be facing.

Scott Whitaker, president and CEO of AdvaMed, recently sat down with Medtech Insight to talk about how the largest medical device industry group is shifting its priorities to tackle the ongoing COVID-19 crisis. While his organization has had to shift the way they operate, they are still working to represent industry’s interests with a focus on helping companies weather the pandemic.

Listen to our full interview in the player below.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126614

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel